Sectra and Philips reunite over PACS in Japan
This article was originally published in Clinica
Swedish medical image management firm Sectra has rekindled a distribution deal with electronics giant Philips for its picture archiving and communications system (PACS) in Japan. The companies had previously worked on a global basis from 1997 until 2005 as part of a deal that saw Philips sell Sectra’s PACS products worldwide. This deal ended when Philips bought US-based PACS firm Stentor for $280m in cash (www.clinica.co.uk, 8 July 2005). The new deal will see Philips sell the product, called Sectra PACS, in Japan under a joint branding policy. According to Linköping-based Sectra, there is still an installed base of around 30 Sectra/Philips PACS systems in Japan from the firms’ previous collaboration. The firm said these systems would act as a “platform and reference for future expansion in the quality-focused and demanding Japanese market”.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals